A possible bidirectional association between migraine and rheumatoid arthritis (RA) is investigated.
Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Sixty-six percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20% in placebo group.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
Higher Children’s Sleep Habits Questionnaire total score correlated with higher frequency of severe attacks, lower drug efficacy.
The researchers performed a systematic review and meta-analyses to determine if epidural steroid injections result in clinically meaningful improvement in lumbosacral radicular syndrome.
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
The majority of APRNs report low levels of preparedness in caring for patients with basic chronic or acute pain management needs in their first year of practice.
The CDC offers 4 resources to support Nurse Practitioners in implementing opioid guidelines.
Global assessments at six and 24 hours better with NSAID use, and fewer adverse effects, including bleeding events, reported
Besides acetaminophen, NSAIDs, triptans, ergot alkaloids, and adjunct antiemetics, gepants and ditans are recently approved for migraine patients.
At follow-up, 65.9% of the treatment group and 8.5% of the control cohort exhibited improvements in painful diabetic neuropathy.
Slightly stronger association was seen for ever users of menopausal hormone therapy than never users.
Researchers sought to determine if a higher cumulative pain intensity is associated with premature mortality risk in patients with PsA.
The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.